Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

BACKGROUND A deleterious effect of complete left bundle-branch block (LBBB) on left ventricular function has been established. Nevertheless, the independent effect of a widened QRS on mortality rate in congestive heart failure (CHF) is still controversial. Therefore, we carried out this analysis to determine whether LBBB is an independent predictor of mortality in CHF. METHODS AND RESULTS We analyzed the large Italian Network on CHF Registry of unselected outpatients with CHF of different causes. The registry was established by the Italian Association of Hospital Cardiologists in 1995. Complete 1-year follow-up data were available for 5517 patients. The main underlying cardiac diagnosis was ischemic heart disease in 2512 patients (45.6%), dilated cardiomyopathy in 1988 patients (36.0%), and hypertensive heart disease in 714 patients (12.9%). Other causes were recorded in the remaining 303 cases (5.5%). LBBB was present in 1391 patients (25.2%) and was associated with an increased 1-year mortality rate from any cause (hazard ratio, 1.70; 95% confidence interval, 1.41 to 2.05) and sudden death (hazard ratio, 1.58; 95% confidence interval, 1.21 to 2.06). Multivariate analysis showed that such an increased risk was still significant after adjusting for age, underlying cardiac disease, indicators of CHF severity, and prescription of angiotensin-converting enzyme inhibitors and beta-blockers. CONCLUSION LBBB is an unfavorable prognostic marker in patients with CHF. The negative effect is independent of age, CHF severity, and drug prescriptions. These data may support the rationale of randomized trials to verify the effects on mortality rate of ventricular resynchronization with multisite cardiac pacing in patients with CHF and LBBB.

[1]  C. H. Chen,et al.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. , 1999, Circulation.

[2]  A. Lazarus,et al.  Multisite stimulation for correction of cardiac asynchrony , 2000, Heart.

[3]  E. Daoud,et al.  Biventricular pacing in patients with congestive heart failure: two prospective randomized trials. The VIGOR CHF and VENTAK CHF Investigators. , 1999, The American journal of cardiology.

[4]  D. Kelly.  Paul Dudley White International Lecture. Our future society. A global challenge. , 1997, Circulation.

[5]  B. Strauer,et al.  The significance of coronary reserve in clinical heart disease. , 1990, Journal of the American College of Cardiology.

[6]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[7]  L. Tavazzi.  Ventricular pacing: a promising new therapeutic strategy in heart failure. For whom? , 2000, European heart journal.

[8]  R. Raddino,et al.  [The prognosis of the patient with heart failure: an analysis of the most significant clinical and instrumental parameters]. , 1991, Cardiologia.

[9]  L. Tavazzi,et al.  Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. , 1998, Journal of the American College of Cardiology.

[10]  N. Danchin,et al.  Additional predictive value of both left and right ventricular ejection fractions on long-term survival in idiopathic dilated cardiomyopathy. , 1997, European heart journal.

[11]  W. Shen,et al.  Clinical significance of complete left bundle branch block in dilated cardiomyopathy. , 1995, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

[12]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[13]  F. Follath,et al.  Etiology and response to drug treatment in heart failure. , 1998, Journal of the American College of Cardiology.

[14]  C. Grines,et al.  Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. , 1989, Circulation.

[15]  S. Gottlieb,et al.  Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. , 1996, Circulation.

[16]  P. Denes,et al.  Sequence and Timing of Ventricular Wall Motion in Patients with Bundle Branch Block: Assessment by Radionuclide Cineangiography , 1982, Circulation.

[17]  P. Fletcher,et al.  VDD Pacing at Short Atrioventricular Intervals Does Not Improve Cardiac Output in Patients with Dilated Heart Failure , 1994, Pacing and clinical electrophysiology : PACE.

[18]  J. Blanc,et al.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.

[19]  J. Cohn,et al.  Prognosis of congestive heart failure and predictors of mortality. , 1988, The American journal of cardiology.

[20]  J. Cohn,et al.  Mild systolic dysfunction in heart failure (left ventricular ejection fraction >35%): baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT) , 1996, Journal of the American College of Cardiology.

[21]  J. Myers,et al.  Cardiopulmonary exercise testing and prognosis in severe heart failure: 14 mL/kg/min revisited. , 2000, American heart journal.

[22]  W. Rand,et al.  Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial. , 1998, Journal of the American College of Cardiology.

[23]  D. Gibson,et al.  Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy. , 1996, International journal of cardiology.

[24]  J. Cohn,et al.  Erratum: Mild systolic dysfunction in heart failure (left ventricular ejection fraction > 35%): Baseline characteristics, prognosis and response to therapy in the Vasodilator in Heart Failure Trials (V-HeFT) (J Am Coll Cardiol (1996), 27:642-9) , 1996 .

[25]  Australia..  Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease , 1997, The Lancet.

[26]  L. Tavazzi,et al.  Comparison of one-year outcome in women versus men with chronic congestive heart failure. , 2000, The American journal of cardiology.

[27]  A. Gavazzi,et al.  [Dilated cardiomyopathy: a new natural history? The experience of the Italian Multicenter Cardiomyopathy Study (SPIC)]. , 1995, Giornale italiano di cardiologia.

[28]  B. Massie,et al.  Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. , 2000, Circulation.

[29]  J. Daubert,et al.  Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. , 1999, The American journal of cardiology.

[30]  R. Shabetai,et al.  Prediction of outcome in late-stage cardiomyopathy. , 1990, American heart journal.

[31]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[32]  L. Erhardt,et al.  Value of 6-min-walk test for assessment of severity and prognosis of heart failure , 2000, The Lancet.

[33]  P. Poole‐Wilson,et al.  Coronary artery disease as the cause of incident heart failure in the population. , 2001, European heart journal.

[34]  H. Suga.  Paul Dudley White International Lecture: cardiac performance as viewed through the pressure-volume window. , 1994, Japanese heart journal.

[35]  A J Belanger,et al.  Epidemiology of heart failure. , 1991, American heart journal.

[36]  M. Block,et al.  The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study. , 1999, The American journal of cardiology.

[37]  S. Gottlieb,et al.  Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise. , 1996, Circulation.

[38]  C. Ng,et al.  Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. , 1990, The American journal of cardiology.

[39]  Thomas Lavergne,et al.  Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay , 2001 .

[40]  D. Gibson,et al.  Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. , 1991, British heart journal.